NFkB is constitutively activated in ER−negative and TN breast tumors, mediates adaptive resistance to ionizing radiation and chemotherapy, and is required for epithelial–mesenchymal transition (EMT) associated with metastatic progression of BC. The gene discussed is NFKB1; the disease is breast neoplasm.